10 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #Tuberculosis #ActiveTB ... #medications #pharmacology ... #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
reach the terminal alveoli ... taken up by the alveolar ... characteristic features Clinical ... and Culture • CXR ... disease • Check CXR
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
reach the terminal alveoli ... taken up by the alveolar ... characteristic features Clinical ... and Culture • CXR ... disease • Check CXR
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... - Imaging: • CXR ... eosinophilia pneumonia, Pulmonary ... Organizing Pneumonia Treatment ... Pneumonia #COP #BOOP #pulmonary
On the left another patient with alveolar edema at admission, which resolved after treatment.
When you scroll
another patient with alveolar ... resolved after treatment ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema
Stage III - Alveolar edema
This stage is characterized by continued fluid leakage into the interstitium, which
After treatment ... redistribution of the pulmonary ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Infection (Diffuse Pulmonary ... • Use until clinical ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... no evidence of active ... HIV-infected persons with clinical ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... muscarinic agonists • Active
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... disease based on clinical ... Note: Active TB ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology